Tenet Healthcare (NYSE:THC) Given New $233.00 Price Target at TD Cowen

Tenet Healthcare (NYSE:THC) had its price objective dropped by equities research analysts at TD Cowen from $242.00 to $233.00 in a research note issued on Monday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. TD Cowen’s price target would suggest a potential upside of 31.48% from the company’s previous close.

A number of other analysts have also commented on THC. Morgan Stanley set a $254.00 price objective on Tenet Healthcare in a research note on Friday, May 1st. Barclays decreased their price target on shares of Tenet Healthcare from $257.00 to $238.00 and set an “overweight” rating on the stock in a research note on Tuesday, May 5th. Royal Bank Of Canada decreased their target price on shares of Tenet Healthcare from $277.00 to $236.00 and set an “outperform” rating on the stock in a research report on Friday, May 1st. Robert W. Baird decreased their price objective on Tenet Healthcare from $245.00 to $210.00 and set a “neutral” rating on the stock in a report on Tuesday, May 5th. Finally, Cantor Fitzgerald reiterated an “overweight” rating on shares of Tenet Healthcare in a research report on Wednesday, March 4th. Eighteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $244.32.

Tenet Healthcare Price Performance

Shares of THC traded up $4.64 on Monday, reaching $177.21. The stock had a trading volume of 344,037 shares, compared to its average volume of 1,247,928. The firm has a 50-day moving average of $182.44 and a 200 day moving average of $198.43. The company has a quick ratio of 1.30, a current ratio of 1.36 and a debt-to-equity ratio of 1.96. The firm has a market capitalization of $15.26 billion, a PE ratio of 9.23, a PEG ratio of 1.42 and a beta of 1.28. Tenet Healthcare has a twelve month low of $146.60 and a twelve month high of $247.21.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings data on Thursday, April 30th. The company reported $4.82 EPS for the quarter, topping the consensus estimate of $4.21 by $0.61. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. The business had revenue of $5.37 billion for the quarter, compared to analyst estimates of $5.39 billion. During the same period in the previous year, the firm earned $4.36 EPS. The business’s revenue for the quarter was up 2.6% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. Sell-side analysts expect that Tenet Healthcare will post 17.61 EPS for the current year.

Insiders Place Their Bets

In other news, Director J Robert Kerrey sold 5,638 shares of the firm’s stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $174.52, for a total value of $983,943.76. Following the transaction, the director directly owned 16,804 shares in the company, valued at $2,932,634.08. This trade represents a 25.12% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Nadja West sold 3,000 shares of Tenet Healthcare stock in a transaction on Wednesday, May 27th. The shares were sold at an average price of $177.35, for a total transaction of $532,050.00. Following the transaction, the director owned 24,805 shares in the company, valued at $4,399,166.75. The trade was a 10.79% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 0.97% of the company’s stock.

Institutional Investors Weigh In On Tenet Healthcare

Several institutional investors and hedge funds have recently modified their holdings of THC. Parallel Advisors LLC raised its position in shares of Tenet Healthcare by 108.9% in the 1st quarter. Parallel Advisors LLC now owns 1,389 shares of the company’s stock valued at $262,000 after purchasing an additional 724 shares in the last quarter. Cozad Asset Management Inc. raised its holdings in Tenet Healthcare by 4.4% in the first quarter. Cozad Asset Management Inc. now owns 6,390 shares of the company’s stock valued at $1,206,000 after acquiring an additional 267 shares in the last quarter. Kentucky Retirement Systems bought a new stake in shares of Tenet Healthcare in the 1st quarter worth about $1,546,000. Bull Harbor Capital LLC acquired a new stake in shares of Tenet Healthcare in the 1st quarter valued at about $720,000. Finally, Amundi grew its stake in Tenet Healthcare by 6.6% in the first quarter. Amundi now owns 71,308 shares of the company’s stock worth $13,457,000 after purchasing an additional 4,404 shares in the last quarter. Hedge funds and other institutional investors own 95.44% of the company’s stock.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.